Invention Grant
- Patent Title: Oral dosage forms comprising progesterone and methods of making and using the same
- Patent Title (中): 包含孕酮的口服剂型及其制备和使用方法
-
Application No.: US11441447Application Date: 2006-05-26
-
Publication No.: US08663681B2Publication Date: 2014-03-04
- Inventor: Salah U. Ahmed , Charles E. Diliberti , Chandra Vattikonda , Sudhir R. Gorukanti , Sanjeev K. Gupta
- Applicant: Salah U. Ahmed , Charles E. Diliberti , Chandra Vattikonda , Sudhir R. Gorukanti , Sanjeev K. Gupta
- Applicant Address: US NJ Woodcliff Lake
- Assignee: Teva Women's Health, Inc.
- Current Assignee: Teva Women's Health, Inc.
- Current Assignee Address: US NJ Woodcliff Lake
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: A61K31/56
- IPC: A61K31/56
Abstract:
The present invention relates to an oral pharmaceutical dosage form comprising micronized progesterone, an edible oil, a disintegrant, and a hydrophilic excipient. Particularly, the invention relates to a pharmaceutical dosage form wherein the dosage form is in a powder form and is contained in a pharmaceutically acceptable capsule. The present invention is also directed toward methods of making the dosage form, methods of using the dosage form, and kits comprising the dosage form.
Public/Granted literature
- US20060275360A1 Oral dosage forms comprising progesterone and methods of making and using the same Public/Granted day:2006-12-07
Information query
